Publications

Federspiel, Jerome J., Lauren E. Wein, Kateena L. Addae-Konadu, Kristin C. Darwin, Laura E. Talamo, Evan R. Myers, and Andra H. James. “Venous thromboembolism incidence among patients recommended for pharmacologic thromboembolism prophylaxis after cesarean delivery in selected guidelines.” Journal of Thrombosis and Haemostasis : Jth, December 21, 2020. https://doi.org/10.1111/jth.15218.

PMID
33345404
Full Text

Ridker, Paul M., Thomas L. Ortel, and Judith S. Hochman. “Equipoise, Trust, and the Need for Cardiologists to Randomly Assign Patients Into Anticoagulation Trials in the Time of COVID.” Circulation 142, no. 24 (December 15, 2020): 2296–98. https://doi.org/10.1161/CIRCULATIONAHA.120.052069.

PMID
33054374
Full Text

Daughety, Molly M., Andrew Morgan, Erin Frost, Chester Kao, Joyce Hwang, Rachel Tobin, Bhavik Patel, Matthew Fuller, Ian Welsby, and Thomas L. Ortel. “COVID-19 associated coagulopathy: Thrombosis, hemorrhage and mortality rates with an escalated-dose thromboprophylaxis strategy.” Thromb Res 196 (December 2020): 483–85. https://doi.org/10.1016/j.thromres.2020.10.004.

PMID
33091700
Full Text

Rondeau, Eric, Marie Scully, Gema Ariceta, Tom Barbour, Spero Cataland, Nils Heyne, Yoshitaka Miyakawa, et al. “Erratum to "Rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon S-S, Kavanagh D, Haller H; on behalf of the 311 Study Group. The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment" Kidney Int. 2020;97:1287-1296.” Kidney Int 98, no. 6 (December 2020): 1621. https://doi.org/10.1016/j.kint.2020.11.001.

PMID
33276869
Full Text

Ridker, Paul M., Thomas L. Ortel, and Judith S. Hochman. “Equipoise, Trust, and the Need for Cardiologists to Randomly Assign Patients Into Anticoagulation Trials in the Time of COVID.” Circulation 142, no. 24 (December 2020): 2296–98. https://doi.org/10.1161/circulationaha.120.052069.

PMID
33054374
Full Text

Ridker, Paul M., Thomas L. Ortel, and Judith S. Hochman. “Equipoise, Trust, and the Need for Cardiologists to Randomly Assign Patients Into Anticoagulation Trials in the Time of COVID.” Circulation 142, no. 24 (December 2020): 2296–98. https://doi.org/10.1161/circulationaha.120.052069.

PMID
33054374
Full Text

Ahmadzia, Homa K., Naomi L. C. Luban, Shuhui Li, Dong Guo, Adam Miszta, Jogarao V. S. Gobburu, Jeffrey S. Berger, Andra H. James, Alisa S. Wolberg, and John van den Anker. “Optimal use of intravenous tranexamic acid for hemorrhage prevention in pregnant women.” American Journal of Obstetrics and Gynecology, November 26, 2020. https://doi.org/10.1016/j.ajog.2020.11.035.

PMID
33248975
Full Text

Ahmadzia, Homa K., Naomi L. C. Luban, Shuhui Li, Dong Guo, Adam Miszta, Jogarao V. S. Gobburu, Jeffrey S. Berger, Andra H. James, Alisa S. Wolberg, and John van den Anker. “Optimal use of intravenous tranexamic acid for hemorrhage prevention in pregnant women.” Am J Obstet Gynecol, November 26, 2020. https://doi.org/10.1016/j.ajog.2020.11.035.

PMID
33248975
Full Text

Oyedeji, Charity I., Tolulpe Oyesanya, Nathan Gray, and John J. Strouse. “Barriers and Facilitators of Advance Care Planning for Older Adults with Sickle Cell Disease.” In Blood, 136:58–59. American Society of Hematology, 2020. https://doi.org/10.1182/blood-2020-136231.

Full Text

Pages